Teva Issues CHF 450 Million 1.50% Notes
Teva Pharmaceutical Finance V B.V. successfully placed CHF 450 million 1.50% notes. The notes have been listed on SIX Swiss Exchange and are guaranteed by Teva Pharmaceutical Industries Limited. Headquartered in Israel, Teva is a leading global pharmaceutical company and world's largest generic drug maker. BNP Paribas (Suisse) SA, Credit Suisse AG and HSBC Bank plc act as joint lead managers on this transaction and Bank Julius Baer & Co. Ltd. as senior co-lead manager.
Bär & Karrer has acted as Swiss legal counsel to Teva in connectio with the issuance and the placement of the notes. Willkie Farr & Gallagher LLP acted as international counsel to Teva. The Bär & Karrer team comprised Eric Stupp, Martin Peyer, Daniel Raun as well as Daniel Lehmann (Tax).